Iomedico Ag

This study looks at how well ropeginterferon alfa-2b works for adults with polycythemia vera (a rare blood cancer) who do not have an enlarged spleen. Researchers will track symptoms, blood cell levels, and side effects over 36 months in about 200 people. The goal is to see if th…

This study follows 150 adults with a specific type of slow-growing brain tumor (grade 2 glioma with an IDH mutation) who are taking the drug vorasidenib after surgery. The main goal is to see how the drug affects their quality of life, including symptoms like seizures. Researcher…

This study looks at how well the drug ivosidenib works for people with a rare and aggressive bile duct cancer that has a specific gene change (IDH1 R132 mutation). About 100 adults in Germany who have already had at least one prior cancer treatment will take ivosidenib as prescri…

This study is observing adults with Waldenström's macroglobulinemia, chronic lymphocytic leukemia, marginal zone lymphoma, or follicular lymphoma who are taking the drug zanubrutinib. Researchers want to see how the drug affects quality of life and how often patients need hospita…

This study is a large registry that will follow about 2,000 people in Germany with advanced ovarian or endometrial cancer. Researchers will collect information on treatments, side effects, quality of life, and survival to understand what really happens in everyday medical practic…